Terveystalo Oy Class A · OMXHEX:TTALO

Terveystalo Oy Class A — Q4 2021 Earnings Presentation

31 slides from Terveystalo Oy Class A's earnings presentation, February 2022

  1. Slide 1: Terveystalo Q4/FY 2021 results: Growing as a stronger business

    Terveystalo Q4/FY 2021 results: Growing as a stronger business VILLE IHO, PRESIDENT & CEO ILKKA LAURILA, CFO 1 FOOTER

  2. Slide 2: Growing as a stronger business

    Growing as a stronger business Good underlying demand despite Omicron surge Strong finish to Record high Covid-19 testing activity the year 2021 Supply bottlenecks compensated by ramping up digital offering All financial targets were achieved Strong core business Record high customer and employee sa

  3. Slide 3: Continued progress against financial and strategic objectives

    Continued progress against financial and strategic objectives 2021 REVENUE +17% 12% ADJ. EBITA NET DEBT/ THE PREFERRED CHOICE BY CUSTOMERS Y-O-Y MARGIN EBITDA 2,5 AND PROFESSIONALS CAGR +14% CAGR 1 155 +18% 141 3,8 1 031 986 115 3,0 88 102 2,8 2,7 RECORD HIGH CUSTOMER 745 73 12 12 2,5 SATISFACTION 6

  4. Slide 4: Strong operational performance to meet record high underlying demand

    Strong operational performance to meet record high underlying demand WE WORK HARD TO RAMP UP THE SUPPLY TO DIGITAL APPOINTMENTS FURTHER IMPROVE DOCTOR APPOINTMENT MEET HIGH DEMAND PRODUCTIVITY AND ACCESS TO CARE BOOKING RATE, % 100 96 96 DIGITAL VISITS, THOUSANDS +363% 95 92 92 93 20% 92 300 89 90 9

  5. Slide 5: Covid-19 related services gave a further boost to the business

    Covid-19 related services gave a further boost to the business RECORD HIGH TESTING ACTIVITY IN Q4 • Terveystalo has gained market share in a 16000 highly competitive market. 14000 • However, the unit prices of the tests have 12000 decreased due to the competition and the 10000 trend is expected to c

  6. Slide 6: Opportunities for value creating capital allocation have improved

    Opportunities for value creating capital allocation have improved OUR DIVIDEND POLICY IS TO DISTRIBUTE AT 0,28 0,28 72% LEAST 40% OF EARNINGS PER SHARE IN 0,26 0,26 DIVIDENDS 0,24 • A dividend of EUR 0.28 (0.26) per share is 0,22 0,20 proposed, corresponding 44% (72%) of 0,20 44% earnings 0,18 37% •

  7. Slide 7: Financial performance

    Financial performance ILKKA LAURILA, CFO 7 FOOTER

  8. Slide 8: Growing as a stronger business also means stronger financials

    Growing as a stronger business also means stronger financials Full year 2021 revenue EUR 1,155 million, + 17% y-o-y Strong revenue growth and profitability – financial Full year 2021 Adj. EBITA EUR 141 million, +38.4% y-o-y and targets achieved 12.2% of revenue Disciplined financial strategy Net deb

  9. Slide 9: All financial targets exceeded in 2021

    All financial targets exceeded in 2021 Target Annual revenue growth Adjusted EBITA margin The target is to The net debt/adjusted of at least 5% through of at least 12–13% in distribute a minimum of EBITDA ratio of 3.5x or organic growth and the medium to long 40% of net profit as less acquisitions t

  10. Slide 10: Strong operational performance

    Strong operational performance RECORD HIGH RECORD HIGH +16% VS. 2020 +48% VS. 2020 CUSTOMER EMPLOYEE SATISFACTION SATISFACTION 230,000 IN 2020 +8% VS. 2020 THE FIGURES DO NOT INCLUDE SWEDEN UNLESS OTHERWISE STATED 10

  11. Slide 11: Strong growth in core business in 2021

    Strong growth in core business in 2021 2021 REVENUE BREAKDOWN, % 2021 REVENUE BREAKDOWN, M€ +17% 3% 1 155 37 986 94 68 0 88 26% 83 121 42% 121 333 295 419 482 29% 2020 2021 Corporate Public Corporate Outsourcing Service sales, OH and others Private Sweden and others Private Staffing Sweden and other

  12. Slide 12: High growth continued in Q4

    High growth continued in Q4 Q4/21 revenue distribution compared to Q4/19 ja Q4/20, M€ +21% +17% 350 Q4/21 vs. Q4/19 Q4/21 vs. Q4/20 328 23 300 270 280 25 0 0 16 22 24 250 23 22 33 37 31 200 89 79 83 150 100 116 121 133 50 0 Q4 2019 Q4 2020 Q4 2021 Corporate Private Outsourcing Staffing services Serv

  13. Slide 13: Profitability reached our targeted level

    Profitability reached our targeted level REVENUE, MEUR AND ADJUSTED EBITDA*-% ADJUSTED EBITA*, MEUR AND % +21.2% +17.1% +29.7% +6.6% 327.5 41.9 39.3 38.2 270.3 279.7 278.7 275.3 273.1 267.8 258.6 257.4 240.2 32.4 32.3 30.9 31.5 234.0 19.2 19.5 19.1 29.5 17.9 17.0 17.7 209.2 17.8 18.1 15.8 16.4 25.9

  14. Slide 14: COVID-19 related services increased personnel costs, cost savings in place in the comparison period

    COVID-19 related services increased personnel costs, cost savings in place in the comparison period M€ 10-12/2021 10-12/2020 Change % 2021 2020 Change % Revenue 327.5 279.7 17.1 1 154.6 986.4 17.1 Other operating income 1.2 0.8 61.6 3.4 2.7 25.3 Purchase of materials -10.4 -9.6 8.9 -34.8 -35.5 -1.9

  15. Slide 15: Strong trend in well-being and digital visits continued

    Strong trend in well-being and digital visits continued WELL-BEING SALES, MEUR DIGITAL VISITS, THOUSANDS +20% +363% 30 9% 20% 300 25 250 20 200 15 150 10 100 5 50 0 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2

  16. Slide 16: We continue to invest in our digital platform

    We continue to invest in our digital platform GROSS CAPEX, MEUR AND %- OF REVENUE NET CAPEX, MEUR AND %- OF REVENUE 4,5 48 4,3 4,3 4,3 4,4 47 46 4,1 4,1 4,2 4,1 4,1 45 3,9 3,9 45 3,9 3,9 44 41 40 3,5 41 3,7 41 5 38 38 3,4 41 39 3,5 37 8 38 38 37 3 19 35 11 4 3,7 18 25 35 16 12 5 5 5 18 21 6 3,4 17 2

  17. Slide 17: Disciplined financial strategy and growing financial strength – capacity to invest in growth

    Disciplined financial strategy and growing financial strength – capacity to invest in growth NET DEBT/ADJUSTED EBITDA (LTM) OPERATIONAL EFFICIENCY IS REFLECTED IN THE NEGATIVE NET WORKING CAPITAL 4,6 7 7 6 4,1 6 6 6 6 6 8 7 8 7 3,5 3,4 3,4 -16,7% 110 109 122 129 128 3,2 101 101 102 100 83 99 95 3,1

  18. Slide 18: Strong cash flow funds our growth, further investments and increasing dividend

    Strong cash flow funds our growth, further investments and increasing dividend OPERATING CASH FLOW 195 174 Dividend distribution 144 at least 40% of earnings 101 Investments to 70 growth M&A to support strategy execution 2017 2018 2019 2020 2021 18 2017-2018 CASH FLOW NOT FULLY COMPARABLE DUE TO IFR

  19. Slide 19: Outlook

    Outlook Outlook – The next 6 months vs. last 6 months Market • The market environment has normalized and the demand for health services is broad and very solid. However, growth is environment restricted by supply. • The demand for services related to COVID-19 is expected to remain good. However, pre

  20. Slide 20: More opportunities for growth

    More opportunities for growth VILLE IHO, PRESIDENT AND CEO 20 FOOTER

  21. Slide 21: We have grown profitably in our core business with industry leading margins, outpacing market growth significantly

    We have grown profitably in our core business with industry leading margins, outpacing market growth significantly TERVEYSTALO CAGR 2015-2021 TERVEYSTALO’S ADDRESSABLE MARKET 2015-2020, €BN 160 1 155 1 200 Total market +1.4% 141 CAGR 4.2 4.1 1 031 4.0 4.0 140 +15% 986 1 000 3.8 3.9 115 120 1.1 1.2 1

  22. Slide 22: Expansion to Sweden offers more opportunities for capital allocation and growth

    Expansion to Sweden offers more opportunities for capital allocation and growth LARGER ADDRESSABLE MARKET MULTIPLE GROWTH AVENUES IN SWEDEN ~30 Private provision market ❑ Organic and in-organic growth in in total EUR 11bn occupational health 7 ❑ Positive organic development, 3 acquisitions completed

  23. Slide 23: New opportunities to scale our proprietary digital suite

    New opportunities to scale our proprietary digital suite Digital health is already mainstream in our business Clear synergy potential in scaling our digital capabilities across our different markets 2 new growth areas emerging: Public sector demand for a white label digital suite In-bound demand fro

  24. Slide 24: Growing as a stronger business

    Growing as a stronger business Good underlying demand despite Omicron surge Strong finish to Record high Covid-19 testing activity the year 2021 Supply bottlenecks compensated by ramping up digital offering All financial targets were achieved Strong core business Record high customer and employee sa

  25. Slide 25: Q&A

    Q&A 25

  26. Slide 26: Terveystalo – Kohti parempaa

    Terveystala Kohti parempaa.

  27. Slide 27: Appendix

    Appendix Terveystalo

  28. Slide 28: Full year revenue grew 17% y-o-y, and 21% vs. 2019

    Full year revenue grew 17% y-o-y, and 21% vs. 2019 2021 revenue breakdown, % 2021 revenue breakdown, M€ 17.1% 3% 1 200 1 155 37 986 94 1 000 0 88 26% 68 83 121 800 42% 121 333 600 295 400 419 482 200 29% 0 2020 2021 Corporate Public Corporate Staffing Private Sweden and others Private Service sales,

  29. Slide 29: Feelgood has been consolidated since the end of June 2021

    Feelgood has been consolidated since the end of June 2021 MEUR 31.12.2021 31.12.2020 • Cash and cash equivalents EUR 38.1 (77.1) million ASSETS • Total assets EUR 1 448.6 (1 361.0) million Property. plant and equipment 72.0 67.6 172.5 172.4 • Equity attributable to owners of the parent company Right

  30. Slide 30: Key figures

    Key figures Terveystalo Group, MEUR 10-12/ 10-12/ Change, % 2021 2020 Change, % 2021 2020 Revenue 327.5 279.7 17.1 1,154.6 986.4 17.1 Adjusted EBITDA, * 1) 59.1 54.5 8.4 206.1 162.8 26.6 Adjusted EBITDA, % * 1) 18.1 19.5 - 17.8 16.5 - EBITDA 1) 58.2 53.7 8.3 201.8 158.3 27.4 EBITDA, % 1) 17.8 19.2 -

  31. Slide 31: Feelgood AB – key figures

    Feelgood AB – key figures SEK, thousand Q1/19 Q2/19 Q3/19 Q4/19 Q1/20 Q2/20 Q3/20 Q4/20 Q1/21 Q2/21 Revenue 204,393 213,110 138,429 220,230 208,448 185,825 125,102 204,733 193,469 206,243 EBITDA 24,371 28,626 -1,612 34,157 24,155 18,486 -464 38,926 20,775 27,167 EBIT 12,921 16,570 -13,704 21,594 11,

Terveystalo — Q4 2021 Earnings Presentation on 6ix